Viewing nowAlzmetin Tablet (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Hungkuk Hyutex Pharmaceutical Co., Ltd.

MFDS item code 201600877 · Approved 2016.02.16 · Insurance code 649102970
Treatment of moderate~severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver is available to regularly confirm that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this drug and the patient’s tolerability of treatment should be reassessed regularly. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7): Administer 5mg once daily for 7 days. Week 2 (days 8-14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15-21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.
This medication should not be used by patients who are allergic to its components, patients with severely impaired liver function, and patients with significantly reduced kidney function. Additionally, this medication contains lactose, and patients with genetic disorders that prevent lactose digestion should not take it. Patients with epilepsy or a history of seizures, as well as those at high risk for seizures, must use this medication with caution. If taken with certain other medications, side effects may increase or persist, so it should not be used with NMDA antagonist class medications. Patients with dietary changes that affect urine acidity or specific diseases should be cautious, and the safety of this medication has not been adequately confirmed in patients with heart disease or uncontrolled hypertension. Taking this medication may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension, and in rare cases, hallucinations or psychotic symptoms have been reported. This medication may interact with other drugs, so if taking any other medications, they must inform their healthcare provider, especially when combined with anticoagulants or certain gastrointestinal medications. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and breastfeeding should be discontinued while taking it. The safety and efficacy of this medication have not been adequately confirmed in children and adolescents under the age of 18. In case of overdose, serious symptoms such as coma, hallucinations, and seizures may occur, so immediate emergency treatment is required, and since there is no specific antidote, symptomatic treatment is necessary. This medication may affect the central nervous system, so caution is required when driving or operating machinery. Finally, this medication should be kept out of the reach of children, and transferring it to another container is important for safety and maintaining quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius, and it is advisable to avoid excessively hot or cold places.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Hungkuk Hyutex Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.